Anti-Human CD279 Recombinant Antibody(Camrelizumab)
-
产品编号
YR1436
-
别名
科研级 Camrelizumab ( 坎利珠单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Camrelizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Camrelizumab ( 坎利珠单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Camrelizumab |
| Catalog Number | YR1436 |
| Molecular Name | Camrelizumab |
| CAS Number | 1798286-48-2 |
| Target | CD279[Homo sapiens] |
| Antibody Isotype | IgG4 Kappa |
| Clonity | Monoclonal |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitionitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials. |
| Application | ELISA, IHC, IF, IP, FCM, Block |
| Remarks | This product is for research use only. |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5栋
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 8:30-18:00 -
-
0
-
